The historical rank and industry rank for The Oncology Institute's Pretax Margin % or its related term are showing as below:
TOI'
s Pretax Margin % Range Over the Past 10 Years
Min: -25.63 Med: -3.71 Max: 4.3
Current: -21.31
TOI's Pretax Margin % is ranked worse than 75.23% of 658
companies
in the Healthcare Providers & Services industry
Industry Median: 2.59
vs TOI: -21.31
The Oncology Institute Pretax Margin % Historical Data
The historical data trend for The Oncology Institute's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of The Oncology Institute's Pretax Margin %
For the Medical Care Facilities subindustry, The Oncology Institute's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Oncology Institute's Pretax Margin % Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Oncology Institute's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where The Oncology Institute's Pretax Margin % falls into.
The Oncology Institute Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
The Oncology Institute's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Oncology Institute (NAS:TOI) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
The Oncology Institute Pretax Margin % Related Terms
Thank you for viewing the detailed overview of The Oncology Institute's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
The Oncology Institute (The Oncology Institute) Business Description
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TOI has been successfully added to your 